Outstanding international researchers have been asked to give keynote or invited lectures.
Keynote and Invited Speakers are:
Mehmet Toner, Harvard University, USA
Mehmet Toner is the Helen Andrus Benedict Professor of Biomedical Engineering at the Massachusetts General Hospital (MGH), Harvard Medical School, and Harvard-MIT Division of Health Sciences and Technology. Mehmet received a BS degree from Istanbul Technical University and an MS degree from the Massachusetts Institute of Technology (MIT), both in Mechanical Engineering. Subsequently he completed his PhD degree in Medical Engineering at Harvard-MIT Division of Health Sciences and Technology in 1989. Mehmet is the co-founding Director of the Center for Engineering in Medicine, and BioMicroElectroMechanical Systems Resource Center (BMRC) at the MGH. He is also the Director of Research at the Shriners Hospital for Children Boston. Mehmet holds over 50 patents, has more than 350 publications, and is a co-founder of multiple biotechnology start-ups. Mehmet is a “Fellow of the American Institute of Medical and Biological Engineering”, “Fellow of the American Society of Mechanical Engineers”, and “Fellow of the Society for Cryobiology.” In 2012, he was given the “Luyet Medal” by the Society for Cryobiology. In 2013, he received the “H.R. Lissner Medal” from the American Society of Mechanical Engineering. He is a member of the “National Academy of Inventors” and “National Academy of Engineers.”
Jochen Guck, TU Dresden, Germany
Dr. Guck received his PhD in Physics from the University of Texas at Austin in 2001. After being a group leader at the University of Leipzig, he moved to the Cavendish Laboratory at Cambridge University as a Lecturer in 2007 and was promoted to Reader in 2009. Since 2012 he is Professor of Cellular Machines at the Biotechnology Center of the Technische Universität Dresden. He has authored about 100 peer-reviewed publications and four patents. His work has been recognized by several awards, amongst them the Cozzarelli Award in 2008, the Paterson Prize in 2011 and an Alexander-von-Humboldt Professorship in 2012.
Mark Sutton, Public Health England, UK
Dr. Sutton graduated from the John Innes Institute with a PhD in molecular microbiology and has worked at Public Health England and its predecessors since 1997. He is currently a Scientific Leader in Healthcare Biotechnology, managing the Technology Development Group. His research interests are mainly in developing novel interventions in the field of applied decontamination science and infection control, the development and evaluation of novel antimicrobial agents and rapid detection and diagnostic systems. His group uses a variety of techniques to develop real life solutions to practical problems, working closely with end users, academic groups and commercial parties. The group takes an interdisciplinary approach, working with a variety of groups in life sciences, chemistry and physical sciences. He has authored more than 50 peer-reviewed publications and he’s a named inventor on more than 15 patent families filed internationally.
Michael Barrett, Glasgow University, UK
Prof Barrett earned his PhD in Pathology 1990 at the University of Cambridge and since 2010 he holds a
tenured position as professor in Biochemical Parasitology at Glasgow University.
Barrett’s research focuses on the biology of African trypanosomes, the causative agents of human African trypanosomiasis as well as Leishmaniasis. In particular, his work focuses on dissecting the biochemistry of these parasites with a view to designing novel diagnostic tools, uncovering new drug targets and learning about mechanisms of drug resistance. Metabolomic and systems biology oriented approaches form part of the current research effort.
He serves on numerous committees within his field of work, among them the committee on trypanosomiasis/leishmaniasis within Training in Tropical Diseases (WHO/TDR) as well as the Expert Committee on Human African trypanosomiasis and the Neglected Tropical Diseases Monitoring of Drug efficacy working group within the World Health Organization.
Barrett is the coauthor of more than 150 publications with more than 5800 citations.
Veerle Lejon, Institut de Recherche pour le Développement, Montpellier, France
Dr Lejon is research director at the Intertryp unit of the French National Research Institute for Sustainable Development (IRD) in Montpellier. Her research focuses on human African trypanosomiasis and she is member of the human African trypanosomiasis expert panel at WHO. She obtained her PhD in 2002, investigating trypanosome invasion in the brain, in search of markers for the neurological disease stage. Until 2013, she continued her research mainly at the Institute of Tropical Medicine in Antwerp, Belgium on shortened post-treatment follow-up, development of antibody detection tests including mimotope discovery and spent 1 year at McGill University in Montreal on discovery of disease markers. Dr Lejons research has always been in close collaboration with partners from endemic countries, and as a diagnostics specialist she is involved in training courses at the academic level and at the level of national control programs. Having spent time with mobile teams in disease endemic zones, she is well aware about the practical challenges faced by control programs in Africa. These form the basis of Dr Lejons actual research interests including human trypanotolerance and diagnostic algorithms adapted to an elimination context, on which she is actually coordinating an EDCTP project.
Henrik Bruus, DTU, Denmark
Henrik Bruus received his PhD degree in physics from the Niels Bohr Institute, University of Copenhagen in 1990, and then worked as postdoc at Nordic Institute of Theoretical Physics 1990-92, Yale University 1992-94 and CNRS Grenoble 1994-96. He returned to the Niels Bohr Institute as associate professor 1997-2001, before moving to the Technical University of Denmark in 2001. There, he became full professor of lab-chip systems in 2005 and of theoretical physics in 2012. His current research interests comprise micro/nanofluidics, acoustofluidics, electrokinetics, the physics of on-chip cell manipulation, the motion of sugar in living plants, and topology-optimized microflows. He has co-authored 140 journal papers on condensed matter physics and microfluidics, 201 conference papers, and 2 monographs, the latest being "Theoretical Microfluidics", Oxford University Press (2008).
BergmanLabora AB is one of
Sweden’s leading suppliers of analytical instruments, microscopy products and apparatus for laboratories. Our core values simplicity, efficiency,
change, freedom and responsibility are leading us in everything we do.
We have more than 100 Years of experience, supplying laboratories with products and solutions from world leading suppliers together with knowledge, service and support.
Through the knowledge and local presence, with a great amount of simplicity, flexibility and personality we help our customers to succeed.
Hamamatsu is a world leader in optoelectronics. We offer the widest product range of components, modules and systems on the market for
science and research and for a broad range of applications within medicine, biotechnology, industry, automation and consumer electronics. Our worldwide organisation with headquarter in Japan has sales and technical support offices around the world.
Hamamatsu Photonics Norden AB is supporting our customers in the Nordic and Baltic countries, Russia and CIS.
© Stefan Holm 2014; last updated 25 August 2017